“It is necessary to establish a system of early access to drugs that provide greater clinical benefit to cancer patients”

Farmaindustria’s Director of Access, Isabel Pineros, analyses the current challenges of access to therapeutic innovation at the Spanish Summit against Cancer, organised by Gepac “We must not forget what it means for a cancer patient to be able to access medicines that allow them to remain connected to their family, social or even work life,” […]

HM Hospitales puts the number of patients in clinical trials of its Research Foundation in 2022 at “almost 1,300”.

Three times the number of three years ago Source: actasanitaria.com The health group HM Hospitales has reported that “almost 1,300” patients participated in 2022 in clinical trials of its Research Foundation (FiHM), which triples the number of three years ago and so “is consolidated as the Spanish private institution of reference in the field of […]

The pharmaceutical industry reaches a record figure for research and development of new medicines

2021 closes with the best R&D investment figures ever: the pharmaceutical industry allocates 1,267 million euros to both private and public projects. Source: elespanol.com Investing in the research and development of new medicines is an essential activity for guaranteeing health and social well-being and improving the healthcare system. A country that is committed to biomedical […]

Pharmaceutical industry launches project to promote patient participation in cross-border clinical trials in the EU

The project is called Borders should no longer be barriers and has been promoted by Efpia and the European Good Clinical Practice Forum, in collaboration with patients and researchers The aim is to bring these studies closer to patients who would otherwise not have access to them because they are trials conducted in other countries, […]

Spain registers more than 900 clinical trials in 2022, above pre-pandemic levels

25% of the studies authorised last year are already for orphan drugs to combat rare diseases 86% of trials are driven by the pharmaceutical industry Javier Urzay, Deputy Director General of Farmaindustria, recalls that “we have the opportunity to further boost Spain’s leadership in this area” Source: farmaindustria.es Spain authorised more than 900 clinical trials […]

“Spain is one of the European countries with the greatest potential for the manufacture of medicines”

The pharmaceutical industry in Spain has a total of 103 production plants, a figure that rises to 173 when active ingredients and veterinary medicines are added Reversing dependence on other countries for drug production is one of the pillars for the development of the Strategic Plan for the Pharmaceutical Industry Farmaindustria participates in the ’20th […]

The pharmaceutical industry reinforces its commitment to Spain and sets a new record in R&D investment, with 1,267 million euros

The figure reached in 2021 is 9% higher than in 2020, when, despite the pandemic, the sector achieved the second best record in its history up to that point Pharmaceutical companies devote nearly half of this investment (593 million euros) to collaborations with hospitals, universities and public and private centres Almost 5,400 employees of the […]

Revolutionary therapy targets the most serious cancers by ‘doping’ the immune system

A Dutch team has developed a cell therapy for metastatic melanoma that improves on the current standard. Source: elespanol.com Researchers in the Netherlands and Denmark have successfully tamed metastatic melanoma using only the patient’s own immune cells. The results, published today in the New England Journal of Medicine, are a testament to a technique that […]

Farmaindustria promotes the creation of a working group to promote clinical trials in primary care

Representatives of scientific societies, public administrations, researchers and pharmaceutical companies make up the group. Clinical research at this level of care has a great opportunity for improvement and this initiative was created with this objective in mind. Between 2004 and 2021, clinical trials involving primary care in Spain have been reduced by half, from 14% […]

AEMPS Bulletin November 2022 on medicinal products for human use

Source: actasanitaria.com This report outlines the medicines already assessed by the Spanish Agency for Medicines and Health Products (AEMPS), which are considered to be of greatest interest to healthcare professionals. These are positive technical opinions from this national regulatory body prior to the authorisation and placing on the market of the medicinal product, which will take […]